Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,560.00
Bid: 4,560.00
Ask: 4,680.00
Change: 110.00 (2.44%)
Spread: 120.00 (2.632%)
Open: 4,540.00
High: 4,660.00
Low: 4,540.00
Prev. Close: 4,510.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on African allegations

8 Oct 2020 17:15

RNS Number : 5632B
Camellia PLC
08 October 2020
 

8 October 2020

Camellia Plc (the "Company")

Update on allegations relating to African operations 

 

As stated in January 2020 and most recently in the interim report in September, Camellia and a number of its subsidiary companies have been put on notice of claims relating to allegations against two companies in its African operations. One of these is Kakuzi Plc in which Camellia bought a controlling stake (50.7%) in the mid-1990s. Kakuzi Plc is quoted on the Nairobi Securities Exchange and is managed by its Board of Directors on behalf of its 1,300 mostly Kenyan shareholders.

Camellia takes any complaint of criminality, misconduct, illegality, or unethical behaviour against its operations very seriously. The allegations are of serious assault, harassment and sexual misconduct allegedly committed by certain individuals apparently employed by the two foreign operating companies. The allegations are being investigated by the two African companies but they are being hindered by UK lawyers Leigh Day's insistence on anonymity.

The two African companies have recognised alternative dispute resolution ("ADR") mechanisms locally so that any allegations are properly examined. If there has been any wrongdoing those responsible will be held to account, and if shortcomings are identified the companies will improve their safeguarding processes and victims will be compensated. Complainants can access independent legal advice, the costs of which will be borne by the operating companies, including if claims fail.

The cost of this ADR process will be expensed in 2020 and in the future and will be in addition to the £4.8m of legal and related costs incurred in 2019 and up to 30 June 2020 as previously disclosed.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Enquiries

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKKFBPPBDDCKK
Date   Source Headline
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update
6th Sep 20222:45 pmRNSInterim Report 2022 - Replacement
1st Sep 20224:00 pmRNSInterim Report 2022
1st Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSTrading Update
1st Jul 202210:54 amRNSResults of Annual General Meeting - 30 June 2022
30th Jun 20227:00 amRNSBF&M Strategic Review
30th Jun 20227:00 amRNSAGM Trading Statement
9th Jun 202211:12 amRNSBoard Committee Changes
6th Jun 20225:22 pmRNSAnnual Report and Notice of AGM
31st May 20227:00 amRNSFinal Results
6th May 20227:00 amRNSDirector Changes and Trading Update
22nd Dec 20217:00 amRNSTrading Update
17th Nov 20217:00 amRNS100% Ownership of Bardsley England
2nd Nov 20217:00 amRNSDirectorate Change
2nd Sep 20212:36 pmRNSInterim Report 2021
2nd Sep 20217:00 amRNSHalf-year Report and changes to Board Committees
25th Aug 202112:42 pmRNSNotice of Interim Results
6th Aug 20218:30 amRNSDeath of Director
5th Aug 20217:00 amRNSSale of Abbey Metal Finishing
2nd Aug 20217:00 amRNSPurchase of Bardsley England
20th Jul 20212:00 pmRNSTrading Update
3rd Jun 20214:15 pmRNSResults of Annual General Meeting - 3 June 2021
3rd Jun 202112:00 pmRNSAGM Trading Statement
5th May 20214:00 pmRNSAnnual Report and Notice of AGM
4th May 20217:00 amRNSFinal Results and Directorate change
29th Apr 20214:30 pmRNSFinal Results - Date of Announcement
11th Feb 20218:00 amRNSTrading update and settlement of claims
16th Nov 20207:00 amRNSCompletion of asset disposal
2nd Nov 20207:15 amRNSGovernance changes
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.